Managing Psoriasis in Patients with HBV or HCV Infection: Practical Considerations
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Managing Psoriasis in Patients with HBV or HCV Infection: Practical Considerations
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-06-20
DOI
10.1007/s40257-019-00457-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- French guidelines on the use of systemic treatments for moderate‐to‐severe psoriasis in adults
- (2019) F. Amatore et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics
- (2019) Alan Menter et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Use of ustekinumab in five psoriatic patients with hepatitis B virus infection
- (2019) Stefano Piaserico et al. GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA
- Treatment of severe psoriasis with ixekizumab in a liver transplant recipient with concomitant hepatitis B virus infection
- (2019) Viviana Lora et al. Dermatologic Therapy
- Safety Profile of Secukinumab in Treatment of Patients with Psoriasis and Concurrent Hepatitis B or C: A Multicentric Prospective Cohort Study
- (2018) H Chiu et al. ACTA DERMATO-VENEREOLOGICA
- Risk of Hepatitis B Reactivation in Patients with Psoriasis on Ustekinumab
- (2018) Sze-Wen Ting et al. CLINICAL DRUG INVESTIGATION
- Patients with core antibody positive and surface antigen negative Hepatitis B (anti-HBc+, HBsAg−) on anti-TNF therapy have a low rate of reactivation
- (2018) William T. Clarke et al. CLINICAL IMMUNOLOGY
- Secukinumab: A positive outcome in a patient with severe psoriasis and HBV-HCV co-infection
- (2018) Francesca Peccerillo et al. Dermatologic Therapy
- Safety and efficacy of HCV eradication during etanercept treatment for severe psoriasis
- (2018) Leonardo Pescitelli et al. Dermatologic Therapy
- Safety of biologic agents for psoriasis in patients with viral hepatitis
- (2018) Nawaf AlMutairi et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Case of psoriatic patient who maintains long-term remission after anti-hepatitis C virus agents and ustekinumab treatment
- (2018) Sota Kikuchi et al. JOURNAL OF DERMATOLOGY
- EASL Recommendations on Treatment of Hepatitis C 2018
- (2018) Jean-Michel Pawlotsky et al. JOURNAL OF HEPATOLOGY
- Psoriatic patients with chronic viral hepatitis do not have an increased risk of liver cirrhosis despite long-term methotrexate use: real-world data from a nationwide cohort study in Taiwan.
- (2018) Kuo-Tung Tang et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Hepatitis B virus reactivation in patients with rheumatoid arthritis: Analysis of the National Database of Japan
- (2018) M. Fujita et al. JOURNAL OF VIRAL HEPATITIS
- Presence of hepatitis B surface antibody in addition to hepatitis B core antibody confers protection against hepatitis B virus infection in hepatitis B surface antigen–negative patients undergoing kidney transplantation
- (2018) Jae Wan Jeon et al. TRANSPLANTATION
- Harmful Effects and Potential Benefits of Anti-Tumor Necrosis Factor (TNF)-α on the Liver
- (2018) Loris Lopetuso et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Hepatitis B Reactivation Associated With Immune Suppressive and Biological Modifier Therapies: Current Concepts, Management Strategies, and Future Directions
- (2017) Rohit Loomba et al. GASTROENTEROLOGY
- Role of surface antibody in hepatitis B reactivation in patients with resolved infection and hematologic malignancy: A meta-analysis
- (2017) Sonali Paul et al. HEPATOLOGY
- EASL Recommendations on Treatment of Hepatitis C 2016
- (2017) JOURNAL OF HEPATOLOGY
- 191 Secukinumab treatment of individuals with psoriasis infected with hepatitis B and/or hepatitis C virus
- (2017) S.A.R. Siegel et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Risk for hepatitis B and C virus reactivation in patients with psoriasis on biologic therapies: A retrospective cohort study and systematic review of the literature
- (2017) Igor Snast et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Adalimumab is a safe option for psoriasis patients with concomitant hepatitis B or C infection: a multicentre cohort study of 37 patients and review of the literature
- (2017) S. Piaserico et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Apremilast for a psoriasis patient with HIV and hepatitis C
- (2017) S.P. Reddy et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Safety of secukinumab in hepatitis B virus
- (2017) S.L. Bevans et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Italian guidelines on the systemic treatments of moderate-to-severe plaque psoriasis
- (2017) P. Gisondi et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Hepatitis B Reactivation in Rheumatic Diseases
- (2017) Christos Koutsianas et al. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
- Timing Strategies of Direct-Acting Antivirals and Biologics Administration in HCV-Infected Subjects with Inflammatory Bowel Diseases
- (2017) Nicola Imperatore et al. Frontiers in Pharmacology
- Immunity and Fibrogenesis: The Role of Th17/IL-17 Axis in HBV and HCV-induced Chronic Hepatitis and Progression to Cirrhosis
- (2017) Feliciano Chanana Paquissi Frontiers in Immunology
- Incidence of hepatitis B virus reactivation in patients with resolved infection on immunosuppressive therapy for rheumatic disease: a multicentre, prospective, observational study in Japan
- (2016) Wataru Fukuda et al. ANNALS OF THE RHEUMATIC DISEASES
- British Association of Dermatologists’ guidelines for the safe and effective prescribing of methotrexate for skin disease 2016
- (2016) R.B. Warren et al. BRITISH JOURNAL OF DERMATOLOGY
- Hepatitis B Virus Reactivation in the Setting of Cancer Chemotherapy and Other Immunosuppressive Drug Therapy
- (2016) Stevan A. Gonzalez et al. CLINICAL INFECTIOUS DISEASES
- Swiss S1 Guidelines on the Systemic Treatment of Psoriasis Vulgaris
- (2016) Antonios G.A. Kolios et al. DERMATOLOGY
- Safety of ustekinumab in severe psoriasis with chronic hepatitis B
- (2016) AneliseRocha Raymundo et al. Indian Journal of Dermatology Venereology & Leprology
- Management of psoriasis patients with hepatitis B or hepatitis C virus infection
- (2016) Claudio Bonifati et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Risk of Drug-Induced Liver Injury From Tumor Necrosis Factor Antagonists
- (2015) Einar S. Björnsson et al. Clinical Gastroenterology and Hepatology
- Are Anti-TNF-α Agents Safe for Treating Psoriasis in Hepatitis C Virus Patients with Advanced Liver Disease? Case Reports and Review of the Literature
- (2015) Sergio Di Nuzzo et al. DERMATOLOGY
- Hepatotoxicity Associated with the Use of Anti-TNF-α Agents
- (2015) Joshua B. French et al. DRUG SAFETY
- American Gastroenterological Association Institute Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy
- (2015) K. Rajender Reddy et al. GASTROENTEROLOGY
- American Gastroenterological Association Institute Technical Review on Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy
- (2015) Robert P. Perrillo et al. GASTROENTEROLOGY
- Safety of long-term biologic therapy in rheumatologic patients with a previously resolved hepatitis B viral infection
- (2015) Michele Barone et al. HEPATOLOGY
- AASLD guidelines for treatment of chronic hepatitis B
- (2015) Norah A. Terrault et al. HEPATOLOGY
- Long-term use of methotrexate does not result in hepatitis B reactivation in rheumatologic patients
- (2015) Charlie Laohapand et al. Hepatology International
- Acitretin-Induced Hepatitis: When to Monitor Cholestatic Enzymes
- (2015) Maxwell B. Sauder et al. JOURNAL OF CUTANEOUS MEDICINE AND SURGERY
- Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013
- (2015) Aparna Schweitzer et al. LANCET
- Hepatitis B virus reactivation associated with antirheumatic therapy: Risk and prophylaxis recommendations
- (2015) Shunsuke Mori WORLD JOURNAL OF GASTROENTEROLOGY
- 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
- (2015) Jasvinder A. Singh et al. ARTHRITIS CARE & RESEARCH
- The use of ustekinumab in a patient with severe psoriasis and positive HBV serology
- (2014) Raquel Bissacotti Steglich et al. ANAIS BRASILEIROS DE DERMATOLOGIA
- Use of Anti-Tumor Necrosis Factor Alpha Therapy in Patients with Concurrent Rheumatoid Arthritis and Hepatitis B or Hepatitis C: A Retrospective Analysis of 32 Patients
- (2014) Eleonora Ballanti et al. DRUG DEVELOPMENT RESEARCH
- Lack of hepatitis B virus reactivation after anti-tumour necrosis factor treatment in potential occult carriers with chronic inflammatory arthropathies
- (2014) M.I. Biondo et al. European Journal of Internal Medicine
- Outcome of patients with serology suggestive of past hepatitis B virus infection during antitumor necrosis factor therapy for psoriasis
- (2014) Raquel Navarro et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Reactivation of hepatitis B virus in rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs
- (2014) Jun Nakamura et al. International Journal of Rheumatic Diseases
- Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease
- (2014) J.F. Rahier et al. Journal of Crohns & Colitis
- Efficacy and safety of ustekinumab treatment in elderly patients with psoriasis
- (2014) Mitsuha Hayashi et al. JOURNAL OF DERMATOLOGY
- A review of methotrexate-associated hepatotoxicity
- (2014) Roopjeet K. Bath et al. Journal of Digestive Diseases
- Safety of Etanercept and Methotrexate in Patients with Rheumatoid Arthritis and Hepatitis C Virus Infection: A Multicenter Randomized Clinical Trial
- (2014) F. Iannone et al. JOURNAL OF RHEUMATOLOGY
- Induction of clinical remission with adalimumab–methotrexate combination therapy in a patient with rheumatoid arthritis and concomitant hepatitis C virus infection
- (2014) Osamu Noguchi et al. Modern Rheumatology
- Past hepatitis B virus infection in rheumatoid arthritis patients receiving biological and/or nonbiological disease-modifying antirheumatic drugs
- (2014) Shunsuke Mori Modern Rheumatology
- Prevalence of reactivation of hepatitis B virus replication in rheumatoid arthritis patients
- (2014) Yukitomo Urata et al. Modern Rheumatology
- Reactivation of hepatitis B virus in a hepatitis B surface antigen-negative patient with rheumatoid arthritis treated with methotrexate
- (2014) Keisuke Watanabe et al. Modern Rheumatology
- Association of hepatitis B with antirheumatic drugs: a case–control study
- (2014) Yasuo Oshima et al. Modern Rheumatology
- The safety profile of ustekinumab in the treatment of patients with psoriasis and concurrent hepatitis B or C
- (2013) H.-Y. Chiu et al. BRITISH JOURNAL OF DERMATOLOGY
- Long-Term Safety of Anti-TNF Adalimumab in HBc Antibody-Positive Psoriatic Arthritis Patients: A Retrospective Case Series of 8 Patients
- (2013) R. Laurenti et al. Clinical & Developmental Immunology
- Liver Injury From Tumor Necrosis Factor-α Antagonists: Analysis of Thirty-four Cases
- (2013) Marwan Ghabril et al. Clinical Gastroenterology and Hepatology
- Anti-TNF therapy in patients with HBV infection—analysis of 87 patients with inflammatory arthritis
- (2013) Hua Ye et al. CLINICAL RHEUMATOLOGY
- Psoriasis treated with ustekinumab in a patient with hepatitis C
- (2013) Adriana Abuchar et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Tumor necrosis factor-α inhibitors and chronic hepatitis C: A comprehensive literature review
- (2013) Maurizio Pompili WORLD JOURNAL OF GASTROENTEROLOGY
- Hepatitis B virus reactivation during therapy with ustekinumab for psoriasis in a hepatitis B surface-antigen-negative anti-HBs-positive patient
- (2012) J. Koskinas et al. BRITISH JOURNAL OF DERMATOLOGY
- Safety and effectiveness of ustekinumab and antitumour necrosis factor therapy in patients with psoriasis and chronic viral hepatitis B or C: a retrospective, multicentre study in a clinical setting
- (2012) R. Navarro et al. BRITISH JOURNAL OF DERMATOLOGY
- Prospective study of HBV reactivation risk in rheumatoid arthritis patients who received conventional disease-modifying antirheumatic drugs
- (2012) Jing Tan et al. CLINICAL RHEUMATOLOGY
- Interleukin-17 Signaling in Inflammatory, Kupffer Cells, and Hepatic Stellate Cells Exacerbates Liver Fibrosis in Mice
- (2012) Fanli Meng et al. GASTROENTEROLOGY
- Prevention of hepatitis B virus reactivation in patients receiving immunosuppressive therapy or chemotherapy
- (2012) Makoto Oketani et al. HEPATOLOGY RESEARCH
- Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-α agents
- (2012) Alfredo Papa et al. Journal of Crohns & Colitis
- Do Low Titers of Antibody Against Hepatitis B Surface Antigen Carry a Risk of Viral Reactivation During Immunosuppressive Therapy for Rheumatic Diseases?
- (2012) S. MORI JOURNAL OF RHEUMATOLOGY
- Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy
- (2011) J.-L. Lan et al. ANNALS OF THE RHEUMATIC DISEASES
- Prospective study of reactivation of hepatitis B virus in patients with rheumatoid arthritis who received immunosuppressive therapy: evaluation of both HBsAg-positive and HBsAg-negative cohorts
- (2011) Akihiro Tamori et al. JOURNAL OF GASTROENTEROLOGY
- Hepatitis B Virus Reactivation by Immunosuppressive Therapy in Patients with Autoimmune Diseases: Risk Analysis in Hepatitis B Surface Antigen-negative Cases
- (2011) MASARU KATO et al. JOURNAL OF RHEUMATOLOGY
- Hepatitis B Virus (HBV) Reactivation in Patients Receiving Tumor Necrosis Factor (TNF)-Targeted Therapy
- (2011) Roberto Pérez-Alvarez et al. MEDICINE
- Long-term safety of anti-TNF treatment in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection
- (2010) D. Vassilopoulos et al. ANNALS OF THE RHEUMATIC DISEASES
- Risk of elevated liver enzymes associated with TNF inhibitor utilisation in patients with rheumatoid arthritis
- (2010) J. Sokolove et al. ANNALS OF THE RHEUMATIC DISEASES
- Safety of antitumour necrosis factor-α therapy in psoriatic patients with hepatitis B virus infection
- (2010) L. Nosotti et al. BRITISH JOURNAL OF DERMATOLOGY
- British Association of Dermatologists guidelines on the efficacy and use of acitretin in dermatology
- (2010) A.D. Ormerod et al. BRITISH JOURNAL OF DERMATOLOGY
- Use of tumor necrosis factor α inhibitors in hepatitis B surface antigen-positive patients: a literature review and potential mechanisms of action
- (2010) Matthew B. Carroll et al. CLINICAL RHEUMATOLOGY
- Hepatitis B virus infection and immunosuppressive therapy in patients with inflammatory bowel disease
- (2010) Filomena Morisco et al. DIGESTIVE AND LIVER DISEASE
- Reactivation of hepatitis B
- (2010) Jay H. Hoofnagle HEPATOLOGY
- Hepatitis B Virus (HBV) Surface Antigen Interacts with and Promotes Cyclophilin A Secretion: Possible Link to Pathogenesis of HBV Infection
- (2010) X. Tian et al. JOURNAL OF VIROLOGY
- Vaccinations in patients with immune-mediated inflammatory diseases
- (2010) J.-F. Rahier et al. RHEUMATOLOGY
- BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies
- (2010) T. Ding et al. RHEUMATOLOGY
- Safety of tumor necrosis factor α blockers in hepatitis B virus occult carriers (hepatitis B surface antigen negative/anti-hepatitis B core antigen positive) with rheumatic diseases
- (2010) R. Caporali et al. ARTHRITIS CARE & RESEARCH
- Etanercept as prophylactic psoriatic therapy before interferon-α and ribavirin treatment for active hepatitis C infection
- (2009) S. E. Behnam et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- Chronic hepatitis B: Update 2009
- (2009) Anna S. F. Lok et al. HEPATOLOGY
- Possible Reactivation of Potential Hepatitis B Virus Occult Infection by Tumor Necrosis Factor- Blocker in the Treatment of Rheumatic Diseases
- (2009) Y. J. KIM et al. JOURNAL OF RHEUMATOLOGY
- Treatment of psoriasis in patients with hepatitis C: From the Medical Board of the National Psoriasis Foundation
- (2009) Amylynne J. Frankel et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Guidelines of care for the management of psoriasis and psoriatic arthritis
- (2009) Alan Menter et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Safety of TNF-blocking agents in rheumatic patients with serology suggesting past hepatitis B state: results from a cohort of 21 patients
- (2009) Caroline Charpin et al. ARTHRITIS RESEARCH & THERAPY
- Use of Tumor Necrosis Factor-α Inhibitors in Patients with Chronic Hepatitis B Infection
- (2008) Matthew B. Carroll et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now